<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Excess body weight, as defined by the body mass index (BMI), has been associated with several diseases and includes subjects who are overweight (BMI≥25-29.9 kg/m(2)) or <z:mp ids='MP_0001261'>obese</z:mp> (BMI≥30 kg/m(2)) </plain></SENT>
<SENT sid="1" pm="."><plain>Overweight and <z:hpo ids='HP_0001513'>obesity</z:hpo> constitute the fifth leading risk for overall mortality, accounting for at least 2.8 million adult <z:hpo ids='HP_0011420'>deaths</z:hpo> each year </plain></SENT>
<SENT sid="2" pm="."><plain>In addition around 11% of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) cases have been attributed to overweight and <z:hpo ids='HP_0001513'>obesity</z:hpo> in Europe </plain></SENT>
<SENT sid="3" pm="."><plain>Epidemiological data suggest that <z:hpo ids='HP_0001513'>obesity</z:hpo> is associated with a 30-70% increased risk of <z:hpo ids='HP_0003003'>colon cancer</z:hpo> in men, whereas the association is less consistent in women </plain></SENT>
<SENT sid="4" pm="."><plain>Similar trends exist for colorectal <z:mpath ids='MPATH_270'>adenoma</z:mpath>, although the risk appears lower </plain></SENT>
<SENT sid="5" pm="."><plain>Visceral fat, or abdominal <z:hpo ids='HP_0001513'>obesity</z:hpo>, seems to be of greater concern than subcutaneous fat <z:hpo ids='HP_0001513'>obesity</z:hpo>, and any 1 kg/m(2) increase in BMI confers additional risk (HR 1.03) </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0001513'>Obesity</z:hpo> might be associated with worse <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> outcomes, such as recurrence of the primary <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> or mortality </plain></SENT>
<SENT sid="7" pm="."><plain>Several factors, including reduced sensitivity to antiangiogenic-therapeutic regimens, might explain these differences </plain></SENT>
<SENT sid="8" pm="."><plain>Except for wound <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e>, <z:hpo ids='HP_0001513'>obesity</z:hpo> has no significant impact on surgical procedures </plain></SENT>
<SENT sid="9" pm="."><plain>The underlying mechanisms linking <z:hpo ids='HP_0001513'>obesity</z:hpo> to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> are still a matter of debate, but <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e>, <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and modifications in levels of adipocytokines seem to be of great importance </plain></SENT>
<SENT sid="10" pm="."><plain>Other biological factors such as the gut microbita or <z:chebi fb="1" ids="3098">bile acids</z:chebi> are emerging </plain></SENT>
<SENT sid="11" pm="?"><plain>Many questions still remain unanswered: should preventive strategies specifically target <z:mp ids='MP_0001261'>obese</z:mp> patients </plain></SENT>
<SENT sid="12" pm="?"><plain>Is the risk of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> great enough to propose prophylactic bariatric surgery in certain patients with <z:hpo ids='HP_0001513'>obesity</z:hpo> </plain></SENT>
</text></document>